Membrane-Bound (MB) Catechol-O-Methyltransferase (COMT) Genetic Polymorphisms, Catechol Estrogen Conjugation and Breast Cancer Risk Reduction

Authors

Y. Ji
James E. Olson, Wright State University - Main CampusFollow
J. Zhang
M. A. Hildebrandt
L. Wang
J. N. Ingle
Z. S. Fredericksen
T. A. Sellers
W. R. Miller
J. M. Dixon
H. Brauch
M. Eichelbaum
C. Justenhoven
U. Hamann
Y. Ko
T. Buening
J. Chang-Claude
S. Wang-Gohrke
D. J. Schaid
R. M. Weinshilboum

Document Type

Conference Proceeding

Publication Date

3-2008

Find in a Library

Catalog Record

Comments

Presented at the 109th Annual Meeting of the American Society for Clinical Pharmacology and Therapeutics, Orlando, FL.

Repository Citation

Ji, Y., Olson, J. E., Zhang, J., Hildebrandt, M. A., Wang, L., Ingle, J. N., Fredericksen, Z. S., Sellers, T. A., Miller, W. R., Dixon, J. M., Brauch, H., Eichelbaum, M., Justenhoven, C., Hamann, U., Ko, Y., Buening, T., Chang-Claude, J., Wang-Gohrke, S., Schaid, D. J., & Weinshilboum, R. M. (2008). Membrane-Bound (MB) Catechol-O-Methyltransferase (COMT) Genetic Polymorphisms, Catechol Estrogen Conjugation and Breast Cancer Risk Reduction. Clinical Pharmacology & Therapeutics, 83 (Supplement 1), S17.
https://corescholar.libraries.wright.edu/ncbp/907

DOI

10.1038/sj.clpt.2008.36